April 2019 – MJZanon IP Attorney – Expert Patent & Trademark Lawyer in Brazil

In Ongoing Adalimumab Litigation With Coherus, Amgen Denies Patent Infringement

Amgen has now answered Coherus BioSciences’ complaint and denies that it has infringed on Coherus’ patents. Amgen also said that the

University of California granted new CRISPR-Cas9 U.S. Patent, further expanding patent portfolio for genome editing

Tuesday, April 23, 2019 Therein lays the problem with most men viagra for suffering from impotence. Fights Diseases and Boosts

Surge of Indian biosimilars market forecast in 2019

22 Apr 2019 India predicted to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new

First international standard on #AI collaboration and security expected by 2020

The world’s first international standard on AI collaboration and security is expected to be published by 2020, which will further